Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

eqs_en 
0 0 24.07.20
DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share
 

DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Forecast/Change in Forecast
Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

24-Jul-2020 / 11:58 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Insider information pursuant to Article 17 MAR

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

Berlin, 24 July 2020. Based on initial, un-audited assessments, revenues and earnings of Berlin-based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) for the half year ending 30 June 2020 are significantly higher than expected.

The consolidated result in the first half of the year should reach EUR 2.47 per share (Q2 previous year: EUR 2.59). At the same time sales should run to about EUR 84 million (Q2 previous year: EUR 89 million).

On the basis of this evaluation, and despite Corona, the Executive Board expects the consolidated result for the financial year 2020 to exceed the forecast published at the beginning of the year. It therefore rescinds the previous guidance and increases the target of EUR 3.50 to EUR 4.00 per share. The Executive Board keeps the revenue forecast at EUR 170 million.

The figures are based on the share capital as of 30 June 2020. Converted to the increased share capital of EUR 21,171,932, the forecast is EUR 1.00 per share.

The complete figures for the first half year 2020 will be published on 13 August 2020.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.de

24-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1100997

 
End of Announcement DGAP News Service

1100997  24-Jul-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1100997&application_name=news&site_id=sharewise

Eckert & Ziegler Strahlen- und Medizintechnik AG Stock

€44.72
-0.350%
The price for the Eckert & Ziegler Strahlen- und Medizintechnik AG stock decreased slightly today. Compared to yesterday there is a change of -€0.160 (-0.350%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Eckert & Ziegler Strahlen- und Medizintechnik AG.
With a target price of 95 € there is potential for a 112.43% increase which would mean more than doubling the current price of 44.72 € for Eckert & Ziegler Strahlen- und Medizintechnik AG.
Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!